Published in J Immunol on September 15, 2007
Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature (2008) 10.80
Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen. Nat Protoc (2009) 3.30
Tools to therapeutically harness the human antibody response. Nat Rev Immunol (2012) 1.30
Ex vivo characterization and isolation of rare memory B cells with antigen tetramers. Blood (2011) 1.21
Identification of antigen-specific B cell receptor sequences using public repertoire analysis. J Immunol (2014) 1.06
An antibody-based biomarker discovery method by mass spectrometry sequencing of complementarity determining regions. Anal Bioanal Chem (2010) 0.96
Single-cell and deep sequencing of IgG-switched macaque B cells reveal a diverse Ig repertoire following immunization. J Immunol (2014) 0.96
In-Depth Assessment of Within-Individual and Inter-Individual Variation in the B Cell Receptor Repertoire. Front Immunol (2015) 0.95
The human IgE repertoire. Int Arch Allergy Immunol (2013) 0.94
Mining human antibody repertoires. MAbs (2010) 0.92
Assessment of humoral immune responses to blood-stage malaria antigens following ChAd63-MVA immunization, controlled human malaria infection and natural exposure. PLoS One (2014) 0.92
Functional analysis of the anti-adalimumab response using patient-derived monoclonal antibodies. J Biol Chem (2014) 0.90
Immune responses are characterized by specific shared immunoglobulin peptides that can be detected by proteomic techniques. J Biol Chem (2010) 0.90
Progress towards recombinant anti-infective antibodies. Recent Pat Antiinfect Drug Discov (2009) 0.88
Back to the future: recombinant polyclonal antibody therapeutics. Curr Opin Chem Eng (2013) 0.86
Proteomic identification of monoclonal antibodies from serum. Anal Chem (2014) 0.84
Characterisation of a panel of anti-tetanus toxin single-chain Fvs reveals cooperative binding. Mol Immunol (2010) 0.82
Single-cell deep phenotyping of IgG-secreting cells for high-resolution immune monitoring. Nat Biotechnol (2017) 0.82
In vitro affinity maturation of a natural human antibody overcomes a barrier to in vivo affinity maturation. MAbs (2014) 0.78
Evolution of B cell analysis and Env trimer redesign. Immunol Rev (2017) 0.76
Diversity of the antibody response to tetanus toxoid: comparison of hybridoma library to phage display library. PLoS One (2014) 0.75
Why does drug resistance readily evolve but vaccine resistance does not? Proc Biol Sci (2017) 0.75
Env-Specific Antibodies in Chronic Infection versus in Vaccination. Front Immunol (2017) 0.75
Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies. Lancet Oncol (2012) 5.70
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet (2013) 4.35
Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer. JAMA (2012) 3.85
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nat Genet (2013) 3.42
Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study. Lancet Oncol (2013) 2.48
Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium. J Natl Cancer Inst (2014) 2.40
Isolation of human antibody repertoires with preservation of the natural heavy and light chain pairing. J Mol Biol (2006) 2.05
Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. Nat Commun (2013) 1.73
Risk of birth abnormalities in the offspring of men with a history of cancer: a cohort study using Danish and Swedish national registries. J Natl Cancer Inst (2011) 1.63
ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: a comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome Atlas. Gynecol Oncol (2013) 1.61
Fertility treatment and childhood cancer risk: a systematic meta-analysis. Fertil Steril (2013) 1.53
Rozrolimupab, a mixture of 25 recombinant human monoclonal RhD antibodies, in the treatment of primary immune thrombocytopenia. Blood (2012) 1.50
Platinum sensitivity-related germline polymorphism discovered via a cell-based approach and analysis of its association with outcome in ovarian cancer patients. Clin Cancer Res (2011) 1.47
Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium. Endocr Relat Cancer (2013) 1.47
Loop electrosurgical excision of the cervix and subsequent risk for spontaneous preterm delivery: a population-based study of singleton deliveries during a 9-year period. Am J Obstet Gynecol (2009) 1.40
Different risk factor profiles for mucinous and nonmucinous ovarian cancer: results from the Danish MALOVA study. Cancer Epidemiol Biomarkers Prev (2007) 1.39
Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31. Nat Commun (2013) 1.36
Depth of cervical cone removed by loop electrosurgical excision procedure and subsequent risk of spontaneous preterm delivery. Obstet Gynecol (2009) 1.32
Trends in the incidence of nonmelanoma skin cancer in Denmark 1978-2007: Rapid incidence increase among young Danish women. Int J Cancer (2010) 1.32
Rational identification of an optimal antibody mixture for targeting the epidermal growth factor receptor. MAbs (2011) 1.29
Limits for antibody affinity maturation and repertoire diversification in hypervaccinated humans. J Immunol (2011) 1.27
Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies. Int J Epidemiol (2013) 1.10
Production of target-specific recombinant human polyclonal antibodies in mammalian cells. Biotechnol Bioeng (2006) 1.10
Cigarette smoking and risk of ovarian cancer: a pooled analysis of 21 case-control studies. Cancer Causes Control (2013) 1.03
Combined and interactive effects of environmental and GWAS-identified risk factors in ovarian cancer. Cancer Epidemiol Biomarkers Prev (2013) 1.02
Do pregnant women still smoke? A study of smoking patterns among 261,029 primiparous women in Denmark 1997-2005. Acta Obstet Gynecol Scand (2008) 1.01
Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA. Hum Genet (2013) 0.99
Novel staphylococcal glycosyltransferases SdgA and SdgB mediate immunogenicity and protection of virulence-associated cell wall proteins. PLoS Pathog (2013) 0.98
Nonsteroidal anti-inflammatory drugs and risk of ovarian cancer: systematic review and meta-analysis of observational studies. Acta Obstet Gynecol Scand (2013) 0.97
Suicide in Danish women evaluated for fertility problems. Hum Reprod (2011) 0.93
Reproductive history and risk of multiple sclerosis. Epidemiology (2011) 0.93
TCR comodulation of nonengaged TCR takes place by a protein kinase C and CD3 gamma di-leucine-based motif-dependent mechanism. J Immunol (2003) 0.92
Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome. Cancer Epidemiol Biomarkers Prev (2013) 0.92
Structural, energetic, and functional analysis of a protein-protein interface at distinct stages of affinity maturation. Structure (2003) 0.91
Social inequality and incidence of and survival from cancer of the female genital organs in a population-based study in Denmark, 1994-2003. Eur J Cancer (2008) 0.91
Malignant melanoma risk after exposure to fertility drugs: results from a large Danish cohort study. Cancer Causes Control (2008) 0.91
Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10. Cancer Res (2013) 0.89
Maternal smoking in pregnancy and risk for congenital malformations: results of a Danish register-based cohort study. Acta Obstet Gynecol Scand (2014) 0.89
Hospital contact for mental disorders in survivors of childhood cancer and their siblings in Denmark: a population-based cohort study. Lancet Oncol (2013) 0.88
Minor structural changes in a mutated human melanoma antigen correspond to dramatically enhanced stimulation of a CD4+ tumor-infiltrating lymphocyte line. J Mol Biol (2002) 0.88
Does educational level determine screening participation? Eur J Cancer Prev (2008) 0.88
Pelvic inflammatory disease and risk of invasive ovarian cancer and ovarian borderline tumors. Cancer Causes Control (2013) 0.87
Human antibody repertoires. Methods Mol Biol (2009) 0.87
Performance of systematic and non-systematic ('opportunistic') screening mammography: a comparative study from Denmark. J Med Screen (2008) 0.85
Risk of ovarian cancer in women with first-degree relatives with cancer. Acta Obstet Gynecol Scand (2009) 0.84
Capturing the natural diversity of the human antibody response against vaccinia virus. J Virol (2010) 0.84
Accuracy of self-reported family history of cancer in a large case-control study of ovarian cancer. Cancer Causes Control (2008) 0.84
The CD3 gamma leucine-based receptor-sorting motif is required for efficient ligand-mediated TCR down-regulation. J Immunol (2002) 0.83
Use of analgesic drugs and risk of ovarian cancer: results from a Danish case-control study. Acta Obstet Gynecol Scand (2012) 0.83
Use of dairy products, lactose, and calcium and risk of ovarian cancer - results from a Danish case-control study. Acta Oncol (2012) 0.83
Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcome. Cancer Immunol Res (2014) 0.82
Improving the pharmacokinetic properties of biologics by fusion to an anti-HSA shark VNAR domain. MAbs (2013) 0.82
Assessing energetic contributions to binding from a disordered region in a protein-protein interaction . Biochemistry (2010) 0.82
Recombinant human polyclonal antibodies: A new class of therapeutic antibodies against viral infections. Curr Pharm Des (2006) 0.82
Reduced susceptibility of recombinant polyclonal antibodies to inhibitory anti-variable domain antibody responses. J Immunol (2006) 0.81
Mobile phone use and the risk of skin cancer: a nationwide cohort study in Denmark. Am J Epidemiol (2013) 0.81
Recent alcohol consumption and risk of incident ovarian carcinoma: a pooled analysis of 5,342 cases and 10,358 controls from the Ovarian Cancer Association Consortium. BMC Cancer (2013) 0.80
Association Between Menopausal Estrogen-Only Therapy and Ovarian Carcinoma Risk. Obstet Gynecol (2016) 0.80
Loop electrosurgical excision of the cervix and risk for spontaneous preterm delivery in twin pregnancies. Obstet Gynecol (2009) 0.79
[HPV infection might play a role in the development of non-melanoma skin cancer in immunocompetent individuals]. Ugeskr Laeger (2012) 0.78
Prognostic value of tissue protein expression levels of MIB-1 (Ki-67) in Danish ovarian cancer patients. From the 'MALOVA' ovarian cancer study. APMIS (2013) 0.77
Does hormone replacement therapy and use of oral contraceptives increase the risk of non-melanoma skin cancer? Cancer Causes Control (2012) 0.77
Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk. Mol Nutr Food Res (2014) 0.77
Is mortalin a candidate gene for T1DM ? Autoimmunity (2004) 0.77
Maternal use of fertility drugs and risk of cancer in children--a nationwide population-based cohort study in Denmark. Int J Cancer (2014) 0.77
Humoral immune response of the small-spotted catshark, Scyliorhinus canicula. Fish Shellfish Immunol (2013) 0.76
Increased risk for cancer among offspring of women with fertility problems. Int J Cancer (2013) 0.76
Kudos for a wonderful fall issue. Md Med (2005) 0.75
Pelvic Inflammatory Disease and the Risk of Ovarian Cancer and Borderline Ovarian Tumors: A Pooled Analysis of 13 Case-Control Studies. Am J Epidemiol (2016) 0.75
Coffee, tea, and caffeine consumption and risk of epithelial ovarian cancer and borderline ovarian tumors: Results from a Danish case-control study. Acta Oncol (2015) 0.75
Tetranectin positive expression in tumour tissue leads to longer survival in Danish women with ovarian cancer. Results from the 'Malova' ovarian cancer study. APMIS (2015) 0.75
Divorce or end of cohabitation among Danish women evaluated for fertility problems. Acta Obstet Gynecol Scand (2014) 0.75
Robust Tests for Additive Gene-Environment Interaction in Case-Control Studies Using Gene-Environment Independence. Am J Epidemiol (2017) 0.75
Biomek 3000: the workhorse in an automated accredited forensic genetic laboratory. J Lab Autom (2012) 0.75
Increased incidence of melanoma in situ in Denmark from 1997 to 2011: results from a nationwide population-based study. Melanoma Res (2014) 0.75
Measuring protein interactions by optical biosensors. Curr Protoc Cell Biol (2004) 0.75